Logiscreen

Kymera Therapeutics Inc

$74.13
Market Cap 6.05B
ROE -25.0%
Gross Margin 100.0%
Debt/Equity 0.1
Current Ratio 10.8
Revenue QoQ 55.5%
EPS QoQ -0.1%
F-Score 4

About

Kymera Therapeutics Inc

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-19.34
vs median 33.61
P/B
3.96
vs median 2.16
ROE
-0.25
vs median 0.09

Lower quality - review fundamentals carefully

Mid-cap company with growth potential

Similar companies

CNTASYRERYTMAPGELEGNPTCT
Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics